𝛼SK or Searchbullish
IPO Databook: Ctt Pharmaceutical Holdings (CTTH US) - Jul 2026
88 Views16 Jul 2026 10:19
SUMMARY
- CTT Pharmaceutical Holdings, Inc. specializes in drug delivery systems technology, focusing on fast-dissolving oral delivery thin dissolvable strips. Commercialization efforts center on nicotine and vitamin strips.
- Net Loss decreased from $(250,229) in FY2024 to $(155,907) in FY2025. Health Canada approved patented THC Strips in 2019, generating CAD $140,000 gross sales.
- Total Assets were $86,168 and Stockholder’s Equity was $55,150 as of December 31, 2025. Auditors report includes a “going concern” qualification.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- IPO Databook: Ctt Pharmaceutical Holdings (CTTH US) - Jul 202616 Jul 2026
x